Exagen Inc.(NasdaqGM:XGN) dropped from Russell 2500 Growth Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.97 USD | 0.00% | +1.81% | -1.01% |
14/05 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
13/05 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.01% | 3.41Cr | |
+22.65% | 8.7TCr | |
-23.68% | 7.56TCr | |
+1.76% | 2.7TCr | |
+3.99% | 1.79TCr | |
-13.47% | 1.66TCr | |
+2.68% | 1.57TCr | |
+69.13% | 1.3TCr | |
+74.99% | 1.29TCr | |
+3.11% | 1.25TCr |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Exagen Inc.(NasdaqGM: XGN) dropped from Russell 2500 Growth Index